Cargando…
Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160281/ https://www.ncbi.nlm.nih.gov/pubmed/34058261 http://dx.doi.org/10.1016/j.jinf.2021.05.026 |
| _version_ | 1783700249788809216 |
|---|---|
| author | Thangaraj, Jeromie Wesley Vivian Kumar, Muthusamy Santhosh Kumar, CP Girish Kumar, V Saravana Kumar, Nathella Pavan Bhatnagar, Tarun Ponnaiah, Manickam Sabarinathan, R Sudharani, D Nancy, Arul Jagadeesan, M Babu, Subash Murhekar, Manoj |
| author_facet | Thangaraj, Jeromie Wesley Vivian Kumar, Muthusamy Santhosh Kumar, CP Girish Kumar, V Saravana Kumar, Nathella Pavan Bhatnagar, Tarun Ponnaiah, Manickam Sabarinathan, R Sudharani, D Nancy, Arul Jagadeesan, M Babu, Subash Murhekar, Manoj |
| author_sort | Thangaraj, Jeromie Wesley Vivian |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8160281 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81602812021-05-28 Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 Thangaraj, Jeromie Wesley Vivian Kumar, Muthusamy Santhosh Kumar, CP Girish Kumar, V Saravana Kumar, Nathella Pavan Bhatnagar, Tarun Ponnaiah, Manickam Sabarinathan, R Sudharani, D Nancy, Arul Jagadeesan, M Babu, Subash Murhekar, Manoj J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-09 2021-05-28 /pmc/articles/PMC8160281/ /pubmed/34058261 http://dx.doi.org/10.1016/j.jinf.2021.05.026 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Thangaraj, Jeromie Wesley Vivian Kumar, Muthusamy Santhosh Kumar, CP Girish Kumar, V Saravana Kumar, Nathella Pavan Bhatnagar, Tarun Ponnaiah, Manickam Sabarinathan, R Sudharani, D Nancy, Arul Jagadeesan, M Babu, Subash Murhekar, Manoj Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title | Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title_full | Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title_fullStr | Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title_full_unstemmed | Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title_short | Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21 |
| title_sort | persistence of humoral immune response to sars-cov-2 up to 7 months post-infection: cross-sectional study, south india, 2020–21 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160281/ https://www.ncbi.nlm.nih.gov/pubmed/34058261 http://dx.doi.org/10.1016/j.jinf.2021.05.026 |
| work_keys_str_mv | AT thangarajjeromiewesleyvivian persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT kumarmuthusamysanthosh persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT kumarcpgirish persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT kumarvsaravana persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT kumarnathellapavan persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT bhatnagartarun persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT ponnaiahmanickam persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT sabarinathanr persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT sudharanid persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT nancyarul persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT jagadeesanm persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT babusubash persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 AT murhekarmanoj persistenceofhumoralimmuneresponsetosarscov2upto7monthspostinfectioncrosssectionalstudysouthindia202021 |